Suvorexant: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Suvorexant. Educational only — not medical advice.
Labeled uses
BELSOMRA® (suvorexant) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
Source: FDA labeling via NIH DailyMed (set e5b72731…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.